This metabolite has a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 roughly fifty% on the father or mother drug. Plasma concentrations of the metabolite are about forty% of those observed for sildenafil, so that the metabolite accounts for around twenty% of sildenafil's pharmacologic outcomes.But Google's latest hap